BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 8833457)

  • 21. Fluticasone propionate and mometasone furoate have a low risk of contact sensitization.
    Wilkinson SM; Beck MH
    Contact Dermatitis; 1996 May; 34(5):365-6. PubMed ID: 8807234
    [No Abstract]   [Full Text] [Related]  

  • 22. Contact hypersensitivity to corticosteroids in routine patch test patients. A multi-centre study of the Swiss Contact Dermatitis Research Group.
    Bircher AJ; Thürlimann W; Hunziker T; Pasche-Koo F; Hunziker N; Perrenoud D; Elsner P; Schultheiss R
    Dermatology; 1995; 191(2):109-14. PubMed ID: 8520055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical corticosteroid allergy in an urban Australian centre.
    Keegel T; Saunders H; Milne R; Sajjachareonpong P; Fletcher A; Nixon R
    Contact Dermatitis; 2004 Jan; 50(1):6-14. PubMed ID: 15059096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed hypersensitivity reactions to corticosteroids applied to mucous membranes.
    Bircher AJ; Pelloni F; Langauer Messmer S; Müller D
    Br J Dermatol; 1996 Aug; 135(2):310-3. PubMed ID: 8881682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone: mometasone furoate study group.
    Lebwohl M
    Int J Dermatol; 1999 Aug; 38(8):604-6. PubMed ID: 10487451
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis.
    Vernon HJ; Lane AT; Weston W
    J Am Acad Dermatol; 1991 Apr; 24(4):603-7. PubMed ID: 2033138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probable active sensitization to tixocortol pivalate.
    Goldsmith PC; White IR; Rycroft RJ; McFadden JP
    Contact Dermatitis; 1995 Dec; 33(6):429. PubMed ID: 8706404
    [No Abstract]   [Full Text] [Related]  

  • 28. Patch Test Reactions to Corticosteroids: Retrospective Analysis From the North American Contact Dermatitis Group 2007-2014.
    Pratt MD; Mufti A; Lipson J; Warshaw EM; Maibach HI; Taylor JS; Sasseville D; DeKoven JG; Zirwas MJ; Fransway AF; Mathias CG; Zug KA; DeLeo VA; Fowler JF; Marks JG; Storrs FJ; Belsito DV
    Dermatitis; 2017; 28(1):58-63. PubMed ID: 28002236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contact hypersensitivity to topical corticosteroids.
    Burden AD; Beck MH
    Br J Dermatol; 1992 Nov; 127(5):497-500. PubMed ID: 1467289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mometasone furoate lotion once daily versus triamcinolone acetonide lotion twice daily in psoriasis.
    Swinehart JM; Barkoff JR; Dvorkin D; Fisher G; Peets E
    Int J Dermatol; 1989 Dec; 28(10):680-1. PubMed ID: 2687182
    [No Abstract]   [Full Text] [Related]  

  • 31. Recommendation to include budesonide and tixocortol pivalate in the European standard series. ESCD and EECDRG. European Society of Contact Dermatitis.
    Isaksson M; Brandão FM; Bruze M; Goossens A
    Contact Dermatitis; 2000 Jul; 43(1):41-2. PubMed ID: 10902588
    [No Abstract]   [Full Text] [Related]  

  • 32. Failure to induce sensitization to budesonide in the guinea pig.
    Isaksson M; Bruze M
    Contact Dermatitis; 2003 Jan; 48(1):50-2. PubMed ID: 12641581
    [No Abstract]   [Full Text] [Related]  

  • 33. In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new.
    Kerscher MJ; Hart H; Korting HC; Stalleicken D
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):187-9. PubMed ID: 7620686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contact allergy to hydrocortisone and systemic contact dermatitis from prednisolone with tolerance of betamethasone.
    Isaksson M; Persson LM
    Am J Contact Dermat; 1998 Jun; 9(2):136-8. PubMed ID: 9601904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple corticosteroid allergies.
    Chow ET
    Australas J Dermatol; 2001 Feb; 42(1):62-3. PubMed ID: 11233727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticosteroid contact hypersensitivity screening in Singapore.
    Khoo BP; Leow YH; Ng SK; Goh CL
    Am J Contact Dermat; 1998 Jun; 9(2):87-91. PubMed ID: 9601908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of elicitation of contact dermatitis in humans by mometasone furoate: evaluation by means of 20-MHz B scanning associated with image analysis.
    Di Nardo A; Giusti G; Mantovani L; Bianchi B; Seidenari S
    Dermatology; 1997; 195(2):137-41. PubMed ID: 9310720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for corticosteroid contact hypersensitivity.
    Boffa MJ; Wilkinson SM; Beck MH
    Contact Dermatitis; 1995 Sep; 33(3):149-51. PubMed ID: 8565453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern of corticosteroid allergy in Thailand.
    Wattanakrai P; Temnithikul B; Pootongkam S
    Dermatitis; 2010; 21(4):203-6. PubMed ID: 20646671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The benefit of patch testing with a corticosteroid at a low concentration.
    Isaksson M; Bruze M; Björkner B; Hindsén M; Svensson L
    Am J Contact Dermat; 1999 Mar; 10(1):31-3. PubMed ID: 10072336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.